DR

Deivandran Rathinavalli

Active Director Managing Director DIN 01536134
DIN 01536134 First appointment Oct 2003 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Oct 2003
Shareholding value •••• Premium profile

About Deivandran Rathinavalli

Data last updated:

Deivandran Rathinavalli is a Managing Director at Swiss Garniers Biotech Private Limited (since 2018), Director at Swiss Garniers Genexiaa Sciences Private Limited (since 2018) and Director at Swiss Garnier Hospitals And Enterprises Private Limited (since 2016), and holds 2 more current directorships. The companies operate in Pharma and Metals and Minerals. The 2 current companies with reported revenue have a combined latest revenue of ₹215 Cr; the largest is Swiss Garniers Biotech Private Limited at ₹136 Cr (FY 2025). Earlier, Deivandran Rathinavalli was a Director at Traditional Ayush Cluster Of Tamilnadu Private Limited (2010–2020).

DIN 01536134
Primary Designation Managing Director
Industry Pharma
First Appointment 07 Oct 2003
Oldest Company Age 24 yrs
Largest company Swiss Garniers Biotech Private Limited · ₹136 Cr (FY 2025)
Combined revenue ₹215 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director02 Jul 20182018₹136 Cr (FY 2025)Active
Director10 Jul 20182018₹79.31 Cr (FY 2025)Active
Director25 Apr 20162016Active
Director21 Feb 20122012Active
Director07 Oct 20032002Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Aug 20102008₹11.4 Lakh (FY 2021)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Swiss Garniers Genexiaa Sciences Private Limited
Swiss Garnier Health Sciences Private Limited
Swiss Garnier Laboratories Private Limited
Swiss Garniers Biotech Private Limited
Premium access

Shareholding and investment profile for Deivandran Rathinavalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deivandran Rathinavalli

Deivandran Rathinavalli currently holds 5 directorships: Swiss Garniers Biotech Private Limited (Managing Director, since 02 Jul 2018, revenue ₹136 Cr (FY 2025)); Swiss Garniers Genexiaa Sciences Private Limited (Director, since 10 Jul 2018, revenue ₹79.31 Cr (FY 2025)); Swiss Garnier Hospitals And Enterprises Private Limited (Director, since 25 Apr 2016); Swiss Garnier Health Sciences Private Limited (Director, since 21 Feb 2012); Swiss Garnier Laboratories Private Limited (Director, since 07 Oct 2003).

Deivandran Rathinavalli was first appointed on 07 Oct 2003 as Director at Swiss Garnier Laboratories Private Limited. The most recent appointment on record is 10 Jul 2018 at Swiss Garniers Genexiaa Sciences Private Limited.

The 2 current companies of Deivandran Rathinavalli that report revenue have a combined latest revenue of ₹215 Cr: Swiss Garniers Biotech Private Limited ₹136 Cr (FY 2025); Swiss Garniers Genexiaa Sciences Private Limited ₹79.31 Cr (FY 2025).

Deivandran Rathinavalli held 1 earlier board appointment: Traditional Ayush Cluster Of Tamilnadu Private Limited (Director, 31 Aug 2010 to 07 Jan 2020).

The current boards of Deivandran Rathinavalli's companies include Muthu Theivendran Subramanian (Swiss Garniers Biotech Private Limited), Vignesh Gandhi (Swiss Garniers Biotech Private Limited), Deivandran Dhrruv Vishnu (Swiss Garniers Genexiaa Sciences Private Limited), Shilpi Deepak Chawla (Swiss Garniers Genexiaa Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available